HUP0500920A2 - Oxadiazole derivatives, process for their preparation and their use - Google Patents

Oxadiazole derivatives, process for their preparation and their use

Info

Publication number
HUP0500920A2
HUP0500920A2 HU0500920A HUP0500920A HUP0500920A2 HU P0500920 A2 HUP0500920 A2 HU P0500920A2 HU 0500920 A HU0500920 A HU 0500920A HU P0500920 A HUP0500920 A HU P0500920A HU P0500920 A2 HUP0500920 A2 HU P0500920A2
Authority
HU
Hungary
Prior art keywords
preparation
oxadiazole derivatives
oxadiazole
derivatives
Prior art date
Application number
HU0500920A
Other languages
Hungarian (hu)
Inventor
Krisztina Dr Gal
Csaba Weber
Gabor Andras Wagner
Attila Dr Horvath
Gyoergyne Dr Nyeki
Monika Dr Vastag
Gyoergy Dr Keserue
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU0500920A priority Critical patent/HUP0500920A2/en
Publication of HU0500920D0 publication Critical patent/HU0500920D0/en
Priority to PCT/HU2006/000087 priority patent/WO2007039781A2/en
Publication of HUP0500920A2 publication Critical patent/HUP0500920A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HU0500920A 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use HUP0500920A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use
PCT/HU2006/000087 WO2007039781A2 (en) 2005-10-05 2006-10-05 New compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use

Publications (2)

Publication Number Publication Date
HU0500920D0 HU0500920D0 (en) 2005-12-28
HUP0500920A2 true HUP0500920A2 (en) 2007-07-30

Family

ID=89986317

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500920A HUP0500920A2 (en) 2005-10-05 2005-10-05 Oxadiazole derivatives, process for their preparation and their use

Country Status (2)

Country Link
HU (1) HUP0500920A2 (en)
WO (1) WO2007039781A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007334436A1 (en) 2006-12-15 2008-06-26 Abbott Laboratories Novel oxadiazole compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
JP2012524798A (en) * 2009-04-23 2012-10-18 メルク・シャープ・エンド・ドーム・コーポレイション 2-alkylpiperidine MGLUR5 receptor modulator
US9421177B2 (en) 2009-08-14 2016-08-23 University Of Virginia Patent Foundation Imidamide sphingosine kinase inhibitors
EP2519521B1 (en) * 2009-12-29 2013-11-20 Eli Lilly and Company Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
CN102762572A (en) 2010-02-01 2012-10-31 诺瓦提斯公司 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (en) 2010-02-01 2012-03-07 Novartis Ag CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS
WO2011095450A1 (en) 2010-02-02 2011-08-11 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
KR20130132816A (en) 2010-10-21 2013-12-05 바이엘 인텔렉쳐 프로퍼티 게엠베하 1-(heterocyclic carbonyl) piperidines
NZ703448A (en) 2012-06-04 2017-07-28 Actelion Pharmaceuticals Ltd Benzimidazole-proline derivatives
CA2885180C (en) 2012-10-10 2021-03-02 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
WO2014141065A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
CA2930053A1 (en) 2013-12-04 2015-06-11 Actelion Pharmaceuticals Ltd Use of benzimidazole-proline derivatives
EP3914592A1 (en) * 2019-01-25 2021-12-01 University of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy
EP4210824A1 (en) * 2020-09-09 2023-07-19 University of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643037A1 (en) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg New oxadiazoles, processes for their preparation and their use as medicines
US7217714B1 (en) * 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US6596731B2 (en) * 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
MXPA05001590A (en) * 2002-08-09 2005-05-23 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors.
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds

Also Published As

Publication number Publication date
HU0500920D0 (en) 2005-12-28
WO2007039781A2 (en) 2007-04-12
WO2007039781A3 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
AP2374A (en) Isoxazoline derivative and novel process for its preparation.
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
EP1937766A4 (en) Modified polyamides, uses thereof and process for their preparation
IL191655A0 (en) Novel compounds, their preparation and use
PL1922309T3 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL187392A0 (en) Thiazole derivatives, their preparation and use
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
PL1988090T3 (en) Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
IL187235A0 (en) 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
EP1961753A4 (en) Pyrazolopyrimidinone derivatives, their preparation and their use
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
PL1874765T3 (en) Urea derivatives, methods for their manufacture and uses thereof
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
IL190221A0 (en) Isoxazole derivatives
SI2020410T1 (en) PyridoŠ2,3-dĆpyrimidine derivatives, process for their preparation and their therapeutical use
EP1907468A4 (en) Process for nanocomposites preparation, and nanocomposites
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL190334A0 (en) Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees